OBAb-2

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOBAb-2
Drug Alias Namegene-delivered tumor specific antibody (Oxford Biomedica)gene-delivered tumor specific antibody (University of Maastricht)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaastricht University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaastricht UniversityOxford Biomedica PLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A